Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, spoke with HCPLive and ConsultantLive at the American Thoracic Society International Conference (ATS) about new data from the AIRFLOW-3 clinical trial. Dr. Criner and the research team assessed the impact of targeted lung denervation on chronic obstructive pulmonary disease (COPD) exacerbations.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH